Your session is about to expire
← Back to Search
Dietary Supplement
Low-dose bitter melon for Prediabetes
N/A
Waitlist Available
Research Sponsored by Midwest Center for Metabolic and Cardiovascular Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 12 weeks
Summary
This trial will study the effects of bitter melon on heart and metabolic health in people with prediabetes.
Eligible Conditions
- Prediabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline up to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Body fat
Fasting glucose
Fasting insulin
+9 moreTrial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Low-dose bitter melonExperimental Treatment1 Intervention
Subject will receive 1 Insumate bitter melon capsule/d (300 mg) and 1 placebo capsule/d (300 mg)
Group II: High-dose bitter melonExperimental Treatment1 Intervention
Subject will receive 2 Insumate bitter melon capsules/d (300 mg each)
Group III: PlaceboPlacebo Group1 Intervention
Subject will receive 2 placebo capsules/d (300 mg each)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-dose bitter melon
2023
N/A
~80
High-dose bitter melon
2023
N/A
~80
Find a Location
Who is running the clinical trial?
Midwest Center for Metabolic and Cardiovascular ResearchLead Sponsor
21 Previous Clinical Trials
809 Total Patients Enrolled
Greenyn BiotechnologyUNKNOWN
Kevin C Maki, PhDStudy DirectorMB Clinical Research & Consulting
16 Previous Clinical Trials
889 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger